Beyond therapeutics, monoclonal antibodies shown to be effective in the clinic can help to facilitate laboratory research. Researchers use mAbs, also known as biosimilars, as tools to research novel therapies and uncover effective off-target applications. With known and approved data on toxicity and efficacy, researchers use these biologics as benchmarks in their studies, allowing them to accelerate their findings from bench to clinic.
ProSci offers more than 800 research-grade biosimilar antibodies in the following research areas: cancer, pain, blood-related diseases, bacterial infection, neurodegenerative, asthma, psoriasis and other dermatitis, rheumatoid arthritis and osteoporosis, inflammatory diseases, Crohn’s disease, virus infection, and diabetes and other autoimmune diseases.
Phone: 02 9698 2022
Amsbio StemFit Basic05 medium for scalable hPSC manufacturing
Compatible with both 2D adherent and 3D suspension culture, StemFit Basic05 enables a streamlined...
GeneTex carrier-free antibodies
GeneTex's carrier-fee antibodies are BSA-, sodium azide- and glycerol-free, featuring diverse...
Cayman Chemical LipidLaunch Ionizable Lipid LNP Screening Set
The LipidLaunch Ionizable Lipid LNP Screening Set is a screening set of 12 ionisable cationic and...
